| Gene name: | MIR101-1 |
| Aging type: | Accelerate |
| Aging characteristic: |
| Tissue type: | -- |
| Cell name: | MCF-7 |
| Experiment: | SA-β-gal activity assay |
| Description: | Further, continuous (upto 72 hrs) over-expression of miR-101 depicted an enhanced induction of senescence(2.3-Fold±0.25). miR-101 inhibition with anti-miR-101 oligonu-cleotides depicted a profile (0.9-Fold 60.25) which matched with the control cells. |
| Target gene: | UBE2N//SMARCA4 |
| Official symbol(s): | UBE2N//SMARCA4 |
| R-AG-Target gene: | Downregulation//Downregulation |
| Subcategory: | Unclear |
| Target gene experiment: | qRT-PCR |
| Target gene description: | The validation of the two targets, UBE2N and SMARCA4, was established by measuring their endogenous cellular expression as well, which decreased significantly in over-expressing miR-101 cells. |
| Regulatory pathway: | -- |
| R-AG-Pathway: | -- |
| Pathway experiment: | -- |
| Pathway description: | -- |
Annotation:
Loading,please wait...